Page last updated: 2024-12-08

metribolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Metribolone: A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

17beta-hydroxy-17-methylestra-4,9,11-trien-3-one : A synthetic non-aromatisable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID261000
CHEMBL ID166444
CHEBI ID379896
SCHEMBL ID114862
MeSH IDM0024129

Synonyms (76)

Synonym
gtpl2857
AKOS015840270
17-beta-hydroxy-17-methylestra-4,9,11-trien-3-one
(17beta)-17-hydroxy-17-methylestra-4,9,11-trien-3-one
estra-4,11-trien-3-one, 17-hydroxy-17-methyl-, (17.beta.)-
nsc92858
17-.alpha.-methyltrienolone
17.alpha.-methyltrienolone
17-.beta.-hydroxy-17-methylestra-4,11-trien-3-one
mls002695156 ,
nsc-92858
estra-4,11-trien-3-one, 17.beta.-hydroxy-17-methyl-
methyl trienolone
ru 1881
17alpha-methyl-17beta-hydroxyestra-4,9(10),11-trien-3-one
3-oxo-17beta-hydroxy-17alpha-methylestra-4,9,11-triene
r 1881
17-beta-hydroxy-17-methyl-19-norandrosta-4,9,11-triene-3-one
17alpha-methyl-4,9,11,estratrien-17beta-ol-3-one
17beta-hydroxy-17-methylestra-4,9,11-trien-3-one
estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17beta)- (9ci)
965-93-5
17alpha-methyl-3-oxo-4,9,11-estratrien-17beta-ol
17alpha-methyltrienolone
methyltrienolone
metribolone
3-oxo-17beta-hydroxy-17-methylestra-4,9,11-triene
17alpha-methyl-17beta-hydroxyestra-4,9,11-trien-3-one
(17beta)-17-hydroxy-17-methyl-estra-4,9,11-triene-3-one
estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17beta)-
estra-4,9,11-trien-3-one, 17beta-hydroxy-17-methyl- (8ci)
17-beta-hydroxy-17-methylestra-4,9,11-trien-3-one (9ci)
estra-4,9,11-trien-3-one, 17beta-hydroxy-17-methyl- (7ci,8ci)
R1881 ,
1XOW
DB02998
2AO6
r-1881
ru-1881
metribolona
metribolonum
17-methyloestra-4,9,11-trien-3-one,17beta-ol
r1881 (synthetic androgen)
CHEBI:379896 ,
CHEMBL166444
(8s,13s,14s,17s)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
A845615
(8s,13s,14s,17s)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,13,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthren-3-one
estra-4,9,11-trien-3-one, 17beta-hydroxy-17-methyl-
metribolone [inn:dcf]
17alpha-methyl-17beta-hydroxyestr-4,9,11-trien-3-one
metribolonum [inn-latin]
nsc 92858
2c323egi97 ,
unii-2c323egi97
metribolona [inn-spanish]
bdbm50367916
1E3G
gtpl3457
[3h]methyltrienolone
[3h]-r1881
[3h]r1881
SCHEMBL114862
metribolone [mart.]
17.beta.-hydroxy-17-methylestra-4,9,11-trien-3-one
metribolone [who-dd]
metribolone [inn]
methyltrienolone [mi]
estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17b)-
DTXSID8034162
17alpha-methyl-17beta-hydroxy-estra-4,9,11-trien-3-one
AC-32028
r1881, >=98% (hplc)
methyltrienolone; 17beta-hydroxy-17methyl-19norandrosta-4,9,11-trien-3-one; r1881
Q3333717
(1s,3as,3bs,11as)-1-hydroxy-1,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,11ah-cyclopenta[a]phenanthren-7-one

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" Our results also indicated that only the aromatizable androgen (TP) or non-aromatizable androgens DHTP and R1881, in combination with oestradiol, reduced sniffing directed to a mismatching female after exposure to vaginal odour."( Olfactory recognition in the male hamster: effect of non-aromatizable androgens, 17 beta-hydroxy-17 alpha-methyl-estra-4,9,11-triene-3-one (R 1881) and 5 alpha-dihydrotestosterone, in combination with oestrogen.
Hutchison, JB; Steel, E, 1986
)
0.27
" Searching for new approaches, we tested a known inducer of cellular differentiation, methotrexate (MTX), in combination with ALA-PDT in LNCaP cells."( Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.
Anand, S; Chang, Y; Hasan, T; Mai, Z; Maytin, EV; Ortel, BJ; Sinha, AK, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves indicated that at physiological concentrations (10(-9) M) 1 alpha,25(OH)2D3 was mitogenic, whereas at higher concentrations (10(-8) M) it promotes differentiation."( The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.
Ferrara, JA; Hedlund, TE; Lucia, MS; Miller, GJ; Pfister, S; Stapleton, GE; Upadhya, P, 1992
)
0.28
" Also, when this higher dosage of testosterone was substituted for each dose of R1881, significant increments in mounting and ejaculation occurred in all groups."( Failure of the synthetic androgen 17 beta-hydroxy-17 alpha-methyl-estra-4,9,11-triene-3-one (methyltrienolone, R1881) to duplicate the activational effect of testosterone on mating in castrated male rats.
Baum, MJ; Erskine, MS; Kingsbury, PA, 1987
)
0.27
"This paper describes the dose-response inhibitory effects of a synthetic androgen, methyltrienolone, on the growth of a grade II endometrial adenocarcinoma in vitro."( Inhibition of endometrial carcinoma cell cultures by a synthetic androgen.
Centola, GM, 1985
)
0.27
" Dose-response analysis for R1881 revealed an ED50 of approximately 2 x 10(-8) M for the synthetic androgen, and comparison with other naturally occurring androgens provided the rank order of potency R1881 > androstenedione > testosterone = dihydrotestosterone."( Androgens augment vasoactive intestinal peptide- and growth hormone-releasing hormone-stimulated progestin production by rat granulosa cells.
Kasson, BG; Li, YD, 1993
)
0.29
" [3H]Thymidine incorporation displayed a bell-shaped dose-response curve in both strains."( LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
Esquenet, M; Heyns, W; Swinnen, JV; Verhoeven, G, 1997
)
0.3
" Dose-response curves can be successfully generated for these compounds, allowing for an assessment of potency."( A multifunctional androgen receptor screening assay using the high-throughput Hypercyt flow cytometry system.
Bowles, HJ; Burchiel, SW; Dennis, MK; Edwards, BS; MacKenzie, DA; Prossnitz, ER; Sklar, LA; Thompson, TA, 2008
)
0.35
" To clarify the role of androgens on TRAIL-induced apoptosis in prostate cancer cells, we investigated the effects of androgen on TRAIL-induced cell death in a dose-response manner."( Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms.
Lu, J; Tindall, DJ; Wang, D, 2013
)
0.39
" Structure-based modification of mifepristone led to the discovery of ORIC-101 (28), a highly potent steroidal GR antagonist with reduced androgen receptor (AR) agonistic activity amenable for dosing in androgen receptor positive tumors and with improved CYP2C8 and CYP2C9 inhibition profile to minimize drug-drug interaction potential."( Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
Chen, C; Du, X; Eksterowicz, J; Fantin, VR; Huang, E; Huang, T; Jackson, E; Jahchan, N; Kawai, H; McGee, LR; Medina, JC; Rew, Y; Sun, D; Sutimantanapi, D; Waszczuk, J; Yan, X; Ye, Q; Zavorotinskaya, T; Zhou, H; Zhu, L, 2018
)
0.48
" This approach ignores potential abnormal dose-response relationships, such as non-monotonic dose-response (NMDR)."( Examining the evidence of non-monotonic dose-response in Androgen Receptor agonism high-throughput screening assay.
Klimenko, K, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
androgenA sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
anabolic androgenic steroidA steroid hormone related to the hormone testosterone. It increases protein synthesis within cells, which results in the buildup of cellular tissue (anabolism), especially in muscles. It also has androgenic and virilizing properties.
17beta-hydroxy steroidA 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration.
3-oxo steroidAny oxo steroid where an oxo substituent is located at position 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucocorticoid receptorHomo sapiens (human)Ki0.00970.00010.38637.0010AID1276600
Progesterone receptorHomo sapiens (human)Ki0.00050.00030.03160.3997AID1276602
Mineralocorticoid receptor Homo sapiens (human)Ki0.00050.00030.17380.8510AID1276601
Sex hormone-binding globulinRattus norvegicus (Norway rat)IC50 (µMol)0.00370.00370.01340.0230AID38689
Androgen receptorHomo sapiens (human)IC50 (µMol)0.00400.00000.875310.0000AID1417054; AID1550915; AID539789
Androgen receptorHomo sapiens (human)Ki0.00040.00020.42407.2000AID1276599
Androgen receptorRattus norvegicus (Norway rat)IC50 (µMol)0.00200.00101.979414.1600AID1885027; AID255211; AID265578
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, androgen receptorHomo sapiens (human)Kd0.00050.00050.00050.0005AID977611
Chain A, androgen receptorHomo sapiens (human)Kd0.00050.00050.00050.0005AID977611
Androgen receptorHomo sapiens (human)EC50 (µMol)0.00010.00000.20794.3000AID1276603; AID1872308
Androgen receptorHomo sapiens (human)Kd0.00090.00030.50246.5200AID238057; AID238058; AID238059; AID238060; AID238061; AID238062; AID238063; AID238064; AID238065; AID478061
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (91)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
regulation of gluconeogenesisGlucocorticoid receptorHomo sapiens (human)
chromatin organizationGlucocorticoid receptorHomo sapiens (human)
regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
apoptotic processGlucocorticoid receptorHomo sapiens (human)
chromosome segregationGlucocorticoid receptorHomo sapiens (human)
signal transductionGlucocorticoid receptorHomo sapiens (human)
glucocorticoid metabolic processGlucocorticoid receptorHomo sapiens (human)
gene expressionGlucocorticoid receptorHomo sapiens (human)
microglia differentiationGlucocorticoid receptorHomo sapiens (human)
adrenal gland developmentGlucocorticoid receptorHomo sapiens (human)
regulation of glucocorticoid biosynthetic processGlucocorticoid receptorHomo sapiens (human)
synaptic transmission, glutamatergicGlucocorticoid receptorHomo sapiens (human)
maternal behaviorGlucocorticoid receptorHomo sapiens (human)
intracellular glucocorticoid receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
glucocorticoid mediated signaling pathwayGlucocorticoid receptorHomo sapiens (human)
positive regulation of neuron apoptotic processGlucocorticoid receptorHomo sapiens (human)
negative regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
astrocyte differentiationGlucocorticoid receptorHomo sapiens (human)
cell divisionGlucocorticoid receptorHomo sapiens (human)
mammary gland duct morphogenesisGlucocorticoid receptorHomo sapiens (human)
motor behaviorGlucocorticoid receptorHomo sapiens (human)
cellular response to steroid hormone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to glucocorticoid stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to dexamethasone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to transforming growth factor beta stimulusGlucocorticoid receptorHomo sapiens (human)
neuroinflammatory responseGlucocorticoid receptorHomo sapiens (human)
positive regulation of miRNA transcriptionGlucocorticoid receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
ovulation from ovarian follicleProgesterone receptorHomo sapiens (human)
glandular epithelial cell maturationProgesterone receptorHomo sapiens (human)
regulation of DNA-templated transcriptionProgesterone receptorHomo sapiens (human)
signal transductionProgesterone receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayProgesterone receptorHomo sapiens (human)
cell-cell signalingProgesterone receptorHomo sapiens (human)
positive regulation of gene expressionProgesterone receptorHomo sapiens (human)
negative regulation of gene expressionProgesterone receptorHomo sapiens (human)
paracrine signalingProgesterone receptorHomo sapiens (human)
negative regulation of phosphorylationProgesterone receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIProgesterone receptorHomo sapiens (human)
lung alveolus developmentProgesterone receptorHomo sapiens (human)
regulation of epithelial cell proliferationProgesterone receptorHomo sapiens (human)
progesterone receptor signaling pathwayProgesterone receptorHomo sapiens (human)
maintenance of protein location in nucleusProgesterone receptorHomo sapiens (human)
tertiary branching involved in mammary gland duct morphogenesisProgesterone receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIProgesterone receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayProgesterone receptorHomo sapiens (human)
signal transductionMineralocorticoid receptor Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionMineralocorticoid receptor Homo sapiens (human)
regulation of transcription by RNA polymerase IIMineralocorticoid receptor Homo sapiens (human)
intracellular steroid hormone receptor signaling pathwayMineralocorticoid receptor Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
MAPK cascadeAndrogen receptorHomo sapiens (human)
in utero embryonic developmentAndrogen receptorHomo sapiens (human)
regulation of systemic arterial blood pressureAndrogen receptorHomo sapiens (human)
epithelial cell morphogenesisAndrogen receptorHomo sapiens (human)
transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
signal transductionAndrogen receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAndrogen receptorHomo sapiens (human)
cell-cell signalingAndrogen receptorHomo sapiens (human)
spermatogenesisAndrogen receptorHomo sapiens (human)
single fertilizationAndrogen receptorHomo sapiens (human)
positive regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
negative regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
positive regulation of gene expressionAndrogen receptorHomo sapiens (human)
male somatic sex determinationAndrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
intracellular receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
Leydig cell differentiationAndrogen receptorHomo sapiens (human)
multicellular organism growthAndrogen receptorHomo sapiens (human)
positive regulation of phosphorylationAndrogen receptorHomo sapiens (human)
positive regulation of MAPK cascadeAndrogen receptorHomo sapiens (human)
positive regulation of insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of cell differentiationAndrogen receptorHomo sapiens (human)
negative regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIIAndrogen receptorHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
regulation of developmental growthAndrogen receptorHomo sapiens (human)
animal organ formationAndrogen receptorHomo sapiens (human)
male genitalia morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell proliferationAndrogen receptorHomo sapiens (human)
negative regulation of epithelial cell proliferationAndrogen receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityAndrogen receptorHomo sapiens (human)
activation of prostate induction by androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
morphogenesis of an epithelial foldAndrogen receptorHomo sapiens (human)
lateral sprouting involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
prostate gland growthAndrogen receptorHomo sapiens (human)
prostate gland epithelium morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell differentiation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
tertiary branching involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
mammary gland alveolus developmentAndrogen receptorHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
cellular response to steroid hormone stimulusAndrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusAndrogen receptorHomo sapiens (human)
cellular response to testosterone stimulusAndrogen receptorHomo sapiens (human)
seminiferous tubule developmentAndrogen receptorHomo sapiens (human)
non-membrane-bounded organelle assemblyAndrogen receptorHomo sapiens (human)
positive regulation of miRNA transcriptionAndrogen receptorHomo sapiens (human)
regulation of protein localization to plasma membraneAndrogen receptorHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayAndrogen receptorHomo sapiens (human)
male gonad developmentAndrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayAndrogen receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (36)

Processvia Protein(s)Taxonomy
RNA polymerase II transcription regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
core promoter sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activityGlucocorticoid receptorHomo sapiens (human)
RNA bindingGlucocorticoid receptorHomo sapiens (human)
nuclear receptor activityGlucocorticoid receptorHomo sapiens (human)
nuclear glucocorticoid receptor activityGlucocorticoid receptorHomo sapiens (human)
steroid bindingGlucocorticoid receptorHomo sapiens (human)
protein bindingGlucocorticoid receptorHomo sapiens (human)
zinc ion bindingGlucocorticoid receptorHomo sapiens (human)
TBP-class protein bindingGlucocorticoid receptorHomo sapiens (human)
protein kinase bindingGlucocorticoid receptorHomo sapiens (human)
identical protein bindingGlucocorticoid receptorHomo sapiens (human)
Hsp90 protein bindingGlucocorticoid receptorHomo sapiens (human)
steroid hormone bindingGlucocorticoid receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingGlucocorticoid receptorHomo sapiens (human)
estrogen response element bindingGlucocorticoid receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingProgesterone receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificProgesterone receptorHomo sapiens (human)
transcription coactivator bindingProgesterone receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificProgesterone receptorHomo sapiens (human)
DNA bindingProgesterone receptorHomo sapiens (human)
nuclear steroid receptor activityProgesterone receptorHomo sapiens (human)
G protein-coupled receptor activityProgesterone receptorHomo sapiens (human)
steroid bindingProgesterone receptorHomo sapiens (human)
protein bindingProgesterone receptorHomo sapiens (human)
zinc ion bindingProgesterone receptorHomo sapiens (human)
enzyme bindingProgesterone receptorHomo sapiens (human)
identical protein bindingProgesterone receptorHomo sapiens (human)
ATPase bindingProgesterone receptorHomo sapiens (human)
estrogen response element bindingProgesterone receptorHomo sapiens (human)
nuclear receptor activityProgesterone receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificMineralocorticoid receptor Homo sapiens (human)
DNA-binding transcription factor activityMineralocorticoid receptor Homo sapiens (human)
nuclear steroid receptor activityMineralocorticoid receptor Homo sapiens (human)
steroid bindingMineralocorticoid receptor Homo sapiens (human)
protein bindingMineralocorticoid receptor Homo sapiens (human)
zinc ion bindingMineralocorticoid receptor Homo sapiens (human)
TBP-class protein bindingMineralocorticoid receptor Homo sapiens (human)
sequence-specific double-stranded DNA bindingMineralocorticoid receptor Homo sapiens (human)
nuclear receptor activityMineralocorticoid receptor Homo sapiens (human)
estrogen response element bindingMineralocorticoid receptor Homo sapiens (human)
transcription cis-regulatory region bindingAndrogen receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
RNA polymerase II general transcription initiation factor bindingAndrogen receptorHomo sapiens (human)
transcription coactivator bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
chromatin bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityAndrogen receptorHomo sapiens (human)
nuclear receptor activityAndrogen receptorHomo sapiens (human)
G protein-coupled receptor activityAndrogen receptorHomo sapiens (human)
signaling receptor bindingAndrogen receptorHomo sapiens (human)
steroid bindingAndrogen receptorHomo sapiens (human)
androgen bindingAndrogen receptorHomo sapiens (human)
protein bindingAndrogen receptorHomo sapiens (human)
beta-catenin bindingAndrogen receptorHomo sapiens (human)
zinc ion bindingAndrogen receptorHomo sapiens (human)
enzyme bindingAndrogen receptorHomo sapiens (human)
ATPase bindingAndrogen receptorHomo sapiens (human)
molecular adaptor activityAndrogen receptorHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingAndrogen receptorHomo sapiens (human)
POU domain bindingAndrogen receptorHomo sapiens (human)
molecular condensate scaffold activityAndrogen receptorHomo sapiens (human)
estrogen response element bindingAndrogen receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleoplasmGlucocorticoid receptorHomo sapiens (human)
cytoplasmGlucocorticoid receptorHomo sapiens (human)
mitochondrial matrixGlucocorticoid receptorHomo sapiens (human)
centrosomeGlucocorticoid receptorHomo sapiens (human)
spindleGlucocorticoid receptorHomo sapiens (human)
cytosolGlucocorticoid receptorHomo sapiens (human)
membraneGlucocorticoid receptorHomo sapiens (human)
nuclear speckGlucocorticoid receptorHomo sapiens (human)
synapseGlucocorticoid receptorHomo sapiens (human)
chromatinGlucocorticoid receptorHomo sapiens (human)
protein-containing complexGlucocorticoid receptorHomo sapiens (human)
plasma membraneProgesterone receptorHomo sapiens (human)
nucleoplasmProgesterone receptorHomo sapiens (human)
mitochondrial outer membraneProgesterone receptorHomo sapiens (human)
cytosolProgesterone receptorHomo sapiens (human)
chromatinProgesterone receptorHomo sapiens (human)
nucleusProgesterone receptorHomo sapiens (human)
nucleoplasmMineralocorticoid receptor Homo sapiens (human)
endoplasmic reticulum membraneMineralocorticoid receptor Homo sapiens (human)
cytosolMineralocorticoid receptor Homo sapiens (human)
chromatinMineralocorticoid receptor Homo sapiens (human)
receptor complexMineralocorticoid receptor Homo sapiens (human)
nucleusMineralocorticoid receptor Homo sapiens (human)
plasma membraneAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
nucleoplasmAndrogen receptorHomo sapiens (human)
cytoplasmAndrogen receptorHomo sapiens (human)
cytosolAndrogen receptorHomo sapiens (human)
nuclear speckAndrogen receptorHomo sapiens (human)
chromatinAndrogen receptorHomo sapiens (human)
protein-containing complexAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (87)

Assay IDTitleYearJournalArticle
AID238061Dissociation constant for [3H]R-1881 binding to human androgen receptor at 298 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID162614Relative binding affinity for progesterone receptor in rat uterine cytosol extract1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID238063Dissociation constant for [3H]R-1881 binding to human androgen receptor at 308 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID238057Dissociation constant for [3H]R-1881 binding to human androgen receptor at 278 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID700052Antagonist activity at AR co-activator binding domain expressed in african green monkey CV1 cells assessed as decrease in R1881-induced luciferase activity at <=40 uM relative to control2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
3,3'-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding.
AID1601345Antagonist activity at androgen receptor (unknown origin) assessed as inhibition of R1881-induced receptor transactivation at 10 uM by dual-luciferase reporter gene assay relative to control2019Bioorganic & medicinal chemistry, 10-15, Volume: 27, Issue:20
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
AID226306Nonspecific binding (NSB) (R1881 = 1.00) calculated using an empirically derived relationship1995Journal of medicinal chemistry, Mar-03, Volume: 38, Issue:5
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
AID162617Relative binding affinity against progestin receptor1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Correspondence analysis applied to steroid receptor binding.
AID39306In vitro relative binding affinity against rat Androgen receptor (rAR)1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
A novel, nonsteroidal inhibitor of androgen binding to the rat androgen binding protein: diethyl [[[3-(2,6-dimethyl-4-pyridinyl)-4-fluorophenyl]amino]methylene] propanedioate.
AID39454Relative binding affinity against androgen receptor1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Correspondence analysis applied to steroid receptor binding.
AID238058Dissociation constant for [3H]R-1881 binding to human androgen receptor at 283 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID39451Binding affinity against cytosolic androgen receptor from ventral prostate of rats using [3H]MIB competitive binding assay (relative to dihydro testosterone)2004Journal of medicinal chemistry, Jul-15, Volume: 47, Issue:15
A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.
AID203786Relative binding affinity (RBA) for Sex steroid binding protein in competitive radiometric assay1995Journal of medicinal chemistry, Mar-03, Volume: 38, Issue:5
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
AID212922Relative binding affinity to the testosterone receptor.1994Journal of medicinal chemistry, Nov-11, Volume: 37, Issue:23
PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.
AID255211Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
AID69372Relative binding affinity for estrogen receptor in rat uterine cytosol extract1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID240008Maximum binding of [3H]R-1881 to human androgen receptor at 288 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID1433573Antagonist activity at androgen receptor (unknown origin) expressed in COS-7 cells assessed as inhibition of R1881-induced MMTV promoter activity at 10 uM by luciferase reporter gene assay relative to control2017European journal of medicinal chemistry, Jan-05, Volume: 125Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer.
AID1872308Modulation of Androgen receptor (unknown origin)2022European journal of medicinal chemistry, Feb-15, Volume: 230Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).
AID1276599Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method2016Journal of medicinal chemistry, Jan-28, Volume: 59, Issue:2
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy.
AID203665In vitro relative binding affinity against hSHBG (human sex hormone binding globulin)1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
A novel, nonsteroidal inhibitor of androgen binding to the rat androgen binding protein: diethyl [[[3-(2,6-dimethyl-4-pyridinyl)-4-fluorophenyl]amino]methylene] propanedioate.
AID1276602Displacement of [3H]-methyltrienolone from progesterone receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method2016Journal of medicinal chemistry, Jan-28, Volume: 59, Issue:2
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy.
AID162462Relative binding affinity to the progesterone receptor.1994Journal of medicinal chemistry, Nov-11, Volume: 37, Issue:23
PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.
AID1885027Binding affinity to rat Androgen receptor in African green monkey COS-7 cells measured by whole-cell binding assay2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Therapeutic Strategies to Target the Androgen Receptor.
AID240012Maximum binding of [3H]R-1881 to human androgen receptor at 308 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID38689Inhibition of rat androgen binding protein (rABP) (n=9)1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
A novel, nonsteroidal inhibitor of androgen binding to the rat androgen binding protein: diethyl [[[3-(2,6-dimethyl-4-pyridinyl)-4-fluorophenyl]amino]methylene] propanedioate.
AID240009Maximum binding of [3H]R-1881 to human androgen receptor at 293K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID39164Relative binding affinity for androgen receptor in MCF-7 cell cytosol extract1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID238062Dissociation constant for [3H]R-1881 binding to human androgen receptor at 303 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID1433574Antiproliferative activity against AR negative human DU145 cells after 3 days by MTT assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer.
AID238060Dissociation constant value of the radiolabeled compound against the androgen receptor 293 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID227714Binding selectivity index (BSI) as ratio of RBA for androgen receptor to non-specific binding of R18811995Journal of medicinal chemistry, Mar-03, Volume: 38, Issue:5
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
AID238065Dissociation constant for [3H]R-1881 binding to human androgen receptor at 273 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID39321Relative binding affinity (RBA) against androgen receptor (AR) using [3H]R-1881 as competitive radioligand.1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID69853Relative binding affinity against Estrogen receptor1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Correspondence analysis applied to steroid receptor binding.
AID1276601Displacement of [3H]-aldosterone from mineralocorticoid receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method2016Journal of medicinal chemistry, Jan-28, Volume: 59, Issue:2
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy.
AID39326Relative affinity for rat androgen receptor(AR) and human Sex steroid binding protein (SBP)1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID1356904Agonist activity at AR in human LNAR cells assessed as increase in TMPRSS2 gene expression at 0.1 nM incubated for 24 hrs in presence of 1 uM enzalutamide by RT-qPCR method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
AID69081Relative binding affinity for estrogen receptor in MCF-7 cell cytosol extract1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID1417054Agonist activity at GAL4 DNA-binding domain fused androgen receptor (unknown origin) ligand binding domain expressed in UAS-bla GripTite 293 cells assessed as beta-lactamase transcriptional activation by FRET-based GeneBLAzer assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs).
AID238064Dissociation constant for [3H]R-1881 binding to human androgen receptor at 310K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID162611Relative binding affinity for progesterone receptor in MCF-7 cell cytosol extract1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID162465Relative binding affinity (RBA) for Progesterone receptor in competitive radiometric assay1995Journal of medicinal chemistry, Mar-03, Volume: 38, Issue:5
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
AID1276603Agonist activity at human androgen receptor expressed in mouse C2C12 cells cotransfected with GRE/ARE reporter plasmid assessed as receptor transactivation after 48 hrs by luciferase reporter gene assay2016Journal of medicinal chemistry, Jan-28, Volume: 59, Issue:2
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy.
AID240010Maximum binding of [3H]R-1881 to human androgen receptor at 298 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID265578Inhibition of rat AR-mediated reporter gene expression in COS7 cells2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
AID711906Inhibition of androgen receptor in human LNCAP cells assessed as reduction in prostate specific antigen secretion at 20 uM after 48 hrs by spectrophotometric analysis2012ACS medicinal chemistry letters, Jun-14, Volume: 3, Issue:6
Nonsteroidal androgen receptor ligands: versatile syntheses and biological data.
AID238059Dissociation constant for [3H]R-1881 binding to human androgen receptor at 288 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID1356901Agonist activity at AR in human LNAR cells assessed as increase in PSA gene expression at 0.1 nM incubated for 24 hrs by RT-qPCR method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
AID1276600Displacement of [3H]-dexamethasone from glucocorticoid receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method2016Journal of medicinal chemistry, Jan-28, Volume: 59, Issue:2
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy.
AID39308Relative binding affinity (RBA) for Androgen receptor in competitive radiometric assay1995Journal of medicinal chemistry, Mar-03, Volume: 38, Issue:5
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
AID287853Binding affinity to human androgen receptor expressed in HEK293 cells at 1 uM relative to R18812007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens.
AID162457Displacement of [3H]R5020 from rat progesterone receptor(PgR)1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID539789Binding affinity to androgen receptor by fluorescence binding assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs).
AID1550915Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay2019European journal of medicinal chemistry, Jun-01, Volume: 171Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer.
AID19824Partition coefficient (logP)1995Journal of medicinal chemistry, Mar-03, Volume: 38, Issue:5
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.
AID74246Relative binding affinity against glucocorticoid receptor in rat liver cytosol extract1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID205637Binding affinity to Steroid Hormone Receptor was determined using [6,7-3H]R5020 as radioligand1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Synthesis and biochemical screening of phenylselenium-substituted steroid hormones.
AID126441Relative binding affinity for the mineralocorticoid receptor1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Correspondence analysis applied to steroid receptor binding.
AID478061Binding affinity to androgen receptor2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.
AID38690In vitro relative binding affinity against rat androgen binding protein (rABP)1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
A novel, nonsteroidal inhibitor of androgen binding to the rat androgen binding protein: diethyl [[[3-(2,6-dimethyl-4-pyridinyl)-4-fluorophenyl]amino]methylene] propanedioate.
AID240006Maximum binding of [3H]-R-1881 to human androgen receptor at 278 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID287852Binding affinity to human androgen receptor expressed in HEK293 cells at 0.1 uM relative to R18812007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens.
AID74389Relative binding affinity against glucocorticoid receptor1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Correspondence analysis applied to steroid receptor binding.
AID240013Maximum binding of the radiolabeled compound towards the androgen receptor at 310K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID1601347Antiproliferative activity against AR-rich human LNCaP-hr cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2019Bioorganic & medicinal chemistry, 10-15, Volume: 27, Issue:20
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
AID126436Displacement of [3H]aldosterone from rat Mineralocorticoid receptor1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID1601346Antiproliferative activity against AR-deficient human PC3 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2019Bioorganic & medicinal chemistry, 10-15, Volume: 27, Issue:20
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
AID1550914Transactivation of AR F876L mutant expressed in human PC3 cells at 0.3 to 10 nM incubated for 24 hrs by dual luciferase reporter gene assay2019European journal of medicinal chemistry, Jun-01, Volume: 171Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer.
AID700053Activation of AR co-activator binding domain expressed in african green monkey CV1 cells at <=40 uM relative to control2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
3,3'-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding.
AID711907Inhibition of androgen receptor in human LNCaP-AR cells assessed as reduction in prostate specific antigen secretion at 20 uM after 48 hrs by spectrophotometric analysis2012ACS medicinal chemistry letters, Jun-14, Volume: 3, Issue:6
Nonsteroidal androgen receptor ligands: versatile syntheses and biological data.
AID39327Relative affinity for rat androgen receptor(AR) and mineralocorticoid receptor(MR)1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID240005Maximum binding of [3H]R-1881 to human androgen receptor at 273 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID240007Maximum binding of [3H]R-1881 to human androgen receptor at 283 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID203784Displacement of [3H]estradiol from human Sex steroid binding protein (SBP)1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID39328Relative affinity for rat androgen receptor(AR) and progesterone receptor(PgR)1992Journal of medicinal chemistry, May-29, Volume: 35, Issue:11
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
AID381439Displacement of [3H]R1881 from human androgen receptor expressed in HEK293 cells relative to control2007The Journal of biological chemistry, Oct-19, Volume: 282, Issue:42
Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12.
AID39168Relative binding affinity for androgen receptor in rat prostate cytosol extract compare to [3H]R-18811994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.
AID1433575Antiproliferative activity against human LNCaP-hr cells expressing AR T877A mutant after 3 days by MTT assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer.
AID1356902Agonist activity at AR in human LNAR cells assessed as increase in TMPRSS2 gene expression at 0.1 nM incubated for 24 hrs by RT-qPCR method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
AID1356903Agonist activity at AR in human LNAR cells assessed as increase in PSA gene expression at 0.1 nM incubated for 24 hrs in presence of 1 uM enzalutamide by RT-qPCR method2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
AID240011Maximum binding of [3H]R-1881 to human androgen receptor at 303 K2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2004Molecular cell, Nov-05, Volume: 16, Issue:3
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
AID1811Experimentally measured binding affinity data derived from PDB2004Molecular cell, Nov-05, Volume: 16, Issue:3
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
AID1346888Human Androgen receptor (3C. 3-Ketosteroid receptors)1998Biochemical pharmacology, May-01, Volume: 55, Issue:9
Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
AID1346911Rat Androgen receptor (3C. 3-Ketosteroid receptors)2003Chemical research in toxicology, Oct, Volume: 16, Issue:10
Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (717)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990289 (40.31)18.7374
1990's151 (21.06)18.2507
2000's170 (23.71)29.6817
2010's99 (13.81)24.3611
2020's8 (1.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.74 (24.57)
Research Supply Index6.61 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index83.75 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (1.08%)6.00%
Case Studies9 (1.21%)4.05%
Observational0 (0.00%)0.25%
Other727 (97.72%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]